Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3099499 | 0.97 | TSHR (0.46) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL27855347 | 0.97 | TSHR (0.46) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL3144356 | 0.94 | TSHR (0.38) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL27379280 | 0.89 | ACHE (0.41) | TSHRTDP1ALDH1A1CYP3A4HCAR2 | |
| SCHEMBL28333557 | 0.87 | ACHE (0.44) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL27505526 | 0.87 | ACHE (0.44) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL28003703 | 0.87 | ACHE (0.44) | TSHRTDP1ALDH1A1CYP3A4NAAA | |
| SCHEMBL368375 | 0.87 | TSHR (0.61) | TSHRALDH1A1CYP3A4NAAAHCAR2 | |
| SCHEMBL34343 | 0.87 | THRB (0.37) | TSHRTDP1ALDH1A1 | |
| SCHEMBL10952662 | 0.86 | CAMK2A (0.38) | TSHRTDP1ALDH1A1CYP3A4HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116554591-A | Biodegradable buffer gas column material master batch and preparation method thereof | 福建省铨丰环保科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-115677988-A | In-situ preparation method of polybutylene oxalate | 大连理工大学 | 2023-02-03 | — | — | CN | claimed |
| CN-115089773-A | Intravascular stent bionic coating, intravascular stent and preparation method thereof | 中国科学院长春应用化学研究所 | 2022-09-23 | — | — | CN | claimed |
| EP-3625284-B1 | POLYESTER COPOLYMER | AVANTIUM KNOWLEDGE CENTRE BV (NL) | 2025-05-07 | — | — | EP | disclosed |
| EP-4493560-A2 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2025-01-22 | — | — | EP | disclosed |
| CN-119285600-A | Preparation method of cyclic alkyl oxalate and ring-opening copolymerization thereof | 青岛科技大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-119192547-A | Low-melt-index polybutylene oxalate and efficient preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-12-27 | — | — | CN | disclosed |
| US-20240317992-A1 | Thermoplastic Resin Composition and Molded Product Manufactured Therefrom | LOTTE CHEMICAL CORPORATION (KR) | 2024-09-26 | — | — | US | disclosed |
| CN-117964889-A | Method for preparing polyoxalate by using composite catalyst and polyoxalate obtained by method | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-115677988-B | In-situ preparation method of polybutylene oxalate | 大连理工大学 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023178111-A2 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| US-20040220356-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040052854-A1 | Porous substances and methods for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1354581-A1 | POROUS SUBSTANCE AND PROCESS FOR PRODUCING THE SAME | Takeda Chemical Industries, Ltd. (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-6217893-B1 | MICROCAPSULES, INSERT | PHARMA BIOTECH (FR) | 2001-04-17 | — | — | US | disclosed |
| EP-0710684-B1 | Preparation process of polyhydroxycarboxylic acid | MITSUI CHEMICALS INC (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-5770683-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0710684-A2 | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040052854-A1 | Porous substances and methods for producing the same | PGF, TACR1, CA3 | TSHR 2307/4885TDP1 3466/4885ALDH1A1 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.